Provided by Tiger Trade Technology Pte. Ltd.

Telix Pharmaceuticals Ltd. (Uplisting)

11.45
+0.60005.53%
Post-market: 11.720.2683+2.34%19:30 EDT
Volume:239.37K
Turnover:2.75M
Market Cap:3.88B
PE:120.04
High:11.79
Open:11.40
Low:11.38
Close:10.85
52wk High:12.48
52wk Low:6.28
Shares:339.00M
Float Shares:272.00M
Volume Ratio:2.02
T/O Rate:0.09%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.0954
EPS(LYR):-0.0211
ROE:7.36%
ROA:2.71%
PB:7.96
PE(LYR):-542.65

Loading ...

RBC Downgrades Telix Pharmaceuticals to Sector Perform From Outperform, Keeps AU$18 Price Target

MT Newswires Live
·
Jul 17

3 Australian Growth Stocks Where Insider Ownership Signals Stronger Conviction

Simply Wall St.
·
Jul 17

Telix Pharmaceuticals Completes Phase Three Enrollment for Prostate Cancer Imaging Study in Japan

MT Newswires Live
·
Jul 17

Telix Pharmaceuticals Opens Radiopharmaceutical Research, Manufacturing, Treatment Facility in Melbourne

MT Newswires Live
·
Jul 16

3 ASX Growth Stocks Backed By Insiders That Could Reward Patient Investors

Simply Wall St.
·
Jul 16

Telix Reports First Patients Dosing in Prostate Cancer Trial

MT Newswires Live
·
Jul 16

Citi Sticks to Their Buy Rating for Telix Pharmaceuticals (TLPPF)

TIPRANKS
·
Jul 15

Citi Sees Positive Catalysts for Telix Pharmaceuticals

Dow Jones
·
Jul 15

3 ASX Growth Stocks Investors Are Watching After Sharp Pullbacks

Simply Wall St.
·
Jul 15

Telix Stock And Two ASX Growth Picks Backed By Insider Ownership

Simply Wall St.
·
Jul 13

3 Fast Growing ASX Stocks With High Insider Ownership to Watch

Simply Wall St.
·
Jul 12

Telix trims potential dilution as conditional share rights lapse

TIPRANKS
·
Jul 10

Telix Pharmaceuticals Issues New Shares After Conversion of Unquoted Securities

TIPRANKS
·
Jul 10

Telix Seeks ASX Quotation for Additional Ordinary Shares

TIPRANKS
·
Jul 10

Fast Growing Australian Stocks Where Insider Ownership Signals Real Skin In The Game

Simply Wall St.
·
Jul 10

Champion Iron Stock And 2 Fast Growing Insider Owned Picks

Simply Wall St.
·
Jul 08

Telix Pharmaceuticals is Maintained at Buy by Citigroup

Dow Jones
·
Jul 08

Telix Pharmaceuticals Price Target Maintained with a $22.00/share by Wedbush

Dow Jones
·
Jul 06

High Insider Ownership Stocks With Real Growth Potential In Australia

Simply Wall St.
·
Jul 06

Analysts Offer Insights on Healthcare Companies: Telix Pharmaceuticals (OtherTLPPF) and Mayne Pharma Group (OtherMAYNF)

TIPRANKS
·
Jul 06